Botulinum neurotoxin type A alleviates mechanical hypersensitivity associated with infraorbital nerve constriction injury in rats

Noboru Noma, Kosuke Watanabe, Yuka Sato, Yoshiki Imamura, Yumiko Yamamoto, Reio Ito, Mitsuru Maruno, Kohei Shimizu, Koichi Iwata

Research output: Contribution to journalArticle

Abstract

We investigated the effect of botulinum neurotoxin type A (BoNT-A) on mechanical allodynia and hyperalgesia associated with infraorbital nerve constriction (ION-CCI) in rats. ION-CCI rats received a subcutaneous BoNT-A injection into the whisker pad area on day 7 postoperatively and underwent pain assessment on days 14 and 21 postoperatively. Rats were assigned to one of four treatment groups (n = 5 each): ION-CCI + BoNT-A 20 pg (low-dose group), ION-CCI + BoNT-A 200 pg (high-dose group), ION-CCI + saline, and Sham. Mechanical allodynia and hyperalgesia were evaluated preoperatively (baseline) and on days 7, 14, and 21 postoperatively. After noxious mechanical stimulation of whisker pad skin, the number and distribution pattern of the phosphorylated extracellular signal-regulated kinase (pERK)-immunoreactive (IR) neurons were analyzed in the trigeminal spinal subnucleus caudalis (Vc) and upper cervical spinal cord (C1-C2). On day 21, nocifensive behavior was attenuated by high-dose but not low-dose BoNT-A administration. In addition, after noxious mechanical stimulation of whisker pad skin, the numbers of pERK-IR cells in the superficial laminae of Vc and C1-C2 were significantly lower in the high-dose BoNT-A group than in the ION-CCI + saline group. The present findings suggest that, by suppressing Vc neuronal activity, high-dose intradermal injection of BoNT-A at the site of ION innervation alleviates mechanical facial allodynia and hyperalgesia associated with ION-CCI.

Original languageEnglish
Pages (from-to)96-101
Number of pages6
JournalNeuroscience Letters
Volume637
DOIs
Publication statusPublished - Jan 10 2017

Fingerprint

Type A Botulinum Toxins
Constriction
Hyperalgesia
Hypersensitivity
Vibrissae
Wounds and Injuries
Extracellular Signal-Regulated MAP Kinases
Intradermal Injections
Skin
Pain Measurement
Neurons
Injections

Keywords

  • Allodynia
  • BoNT-A
  • Hyperalgesia
  • ION-CCI
  • pERK

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Botulinum neurotoxin type A alleviates mechanical hypersensitivity associated with infraorbital nerve constriction injury in rats. / Noma, Noboru; Watanabe, Kosuke; Sato, Yuka; Imamura, Yoshiki; Yamamoto, Yumiko; Ito, Reio; Maruno, Mitsuru; Shimizu, Kohei; Iwata, Koichi.

In: Neuroscience Letters, Vol. 637, 10.01.2017, p. 96-101.

Research output: Contribution to journalArticle

Noma, Noboru ; Watanabe, Kosuke ; Sato, Yuka ; Imamura, Yoshiki ; Yamamoto, Yumiko ; Ito, Reio ; Maruno, Mitsuru ; Shimizu, Kohei ; Iwata, Koichi. / Botulinum neurotoxin type A alleviates mechanical hypersensitivity associated with infraorbital nerve constriction injury in rats. In: Neuroscience Letters. 2017 ; Vol. 637. pp. 96-101.
@article{f594a3c2f4a445f298d09e419206b8c6,
title = "Botulinum neurotoxin type A alleviates mechanical hypersensitivity associated with infraorbital nerve constriction injury in rats",
abstract = "We investigated the effect of botulinum neurotoxin type A (BoNT-A) on mechanical allodynia and hyperalgesia associated with infraorbital nerve constriction (ION-CCI) in rats. ION-CCI rats received a subcutaneous BoNT-A injection into the whisker pad area on day 7 postoperatively and underwent pain assessment on days 14 and 21 postoperatively. Rats were assigned to one of four treatment groups (n = 5 each): ION-CCI + BoNT-A 20 pg (low-dose group), ION-CCI + BoNT-A 200 pg (high-dose group), ION-CCI + saline, and Sham. Mechanical allodynia and hyperalgesia were evaluated preoperatively (baseline) and on days 7, 14, and 21 postoperatively. After noxious mechanical stimulation of whisker pad skin, the number and distribution pattern of the phosphorylated extracellular signal-regulated kinase (pERK)-immunoreactive (IR) neurons were analyzed in the trigeminal spinal subnucleus caudalis (Vc) and upper cervical spinal cord (C1-C2). On day 21, nocifensive behavior was attenuated by high-dose but not low-dose BoNT-A administration. In addition, after noxious mechanical stimulation of whisker pad skin, the numbers of pERK-IR cells in the superficial laminae of Vc and C1-C2 were significantly lower in the high-dose BoNT-A group than in the ION-CCI + saline group. The present findings suggest that, by suppressing Vc neuronal activity, high-dose intradermal injection of BoNT-A at the site of ION innervation alleviates mechanical facial allodynia and hyperalgesia associated with ION-CCI.",
keywords = "Allodynia, BoNT-A, Hyperalgesia, ION-CCI, pERK",
author = "Noboru Noma and Kosuke Watanabe and Yuka Sato and Yoshiki Imamura and Yumiko Yamamoto and Reio Ito and Mitsuru Maruno and Kohei Shimizu and Koichi Iwata",
year = "2017",
month = "1",
day = "10",
doi = "10.1016/j.neulet.2016.11.043",
language = "English",
volume = "637",
pages = "96--101",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Botulinum neurotoxin type A alleviates mechanical hypersensitivity associated with infraorbital nerve constriction injury in rats

AU - Noma, Noboru

AU - Watanabe, Kosuke

AU - Sato, Yuka

AU - Imamura, Yoshiki

AU - Yamamoto, Yumiko

AU - Ito, Reio

AU - Maruno, Mitsuru

AU - Shimizu, Kohei

AU - Iwata, Koichi

PY - 2017/1/10

Y1 - 2017/1/10

N2 - We investigated the effect of botulinum neurotoxin type A (BoNT-A) on mechanical allodynia and hyperalgesia associated with infraorbital nerve constriction (ION-CCI) in rats. ION-CCI rats received a subcutaneous BoNT-A injection into the whisker pad area on day 7 postoperatively and underwent pain assessment on days 14 and 21 postoperatively. Rats were assigned to one of four treatment groups (n = 5 each): ION-CCI + BoNT-A 20 pg (low-dose group), ION-CCI + BoNT-A 200 pg (high-dose group), ION-CCI + saline, and Sham. Mechanical allodynia and hyperalgesia were evaluated preoperatively (baseline) and on days 7, 14, and 21 postoperatively. After noxious mechanical stimulation of whisker pad skin, the number and distribution pattern of the phosphorylated extracellular signal-regulated kinase (pERK)-immunoreactive (IR) neurons were analyzed in the trigeminal spinal subnucleus caudalis (Vc) and upper cervical spinal cord (C1-C2). On day 21, nocifensive behavior was attenuated by high-dose but not low-dose BoNT-A administration. In addition, after noxious mechanical stimulation of whisker pad skin, the numbers of pERK-IR cells in the superficial laminae of Vc and C1-C2 were significantly lower in the high-dose BoNT-A group than in the ION-CCI + saline group. The present findings suggest that, by suppressing Vc neuronal activity, high-dose intradermal injection of BoNT-A at the site of ION innervation alleviates mechanical facial allodynia and hyperalgesia associated with ION-CCI.

AB - We investigated the effect of botulinum neurotoxin type A (BoNT-A) on mechanical allodynia and hyperalgesia associated with infraorbital nerve constriction (ION-CCI) in rats. ION-CCI rats received a subcutaneous BoNT-A injection into the whisker pad area on day 7 postoperatively and underwent pain assessment on days 14 and 21 postoperatively. Rats were assigned to one of four treatment groups (n = 5 each): ION-CCI + BoNT-A 20 pg (low-dose group), ION-CCI + BoNT-A 200 pg (high-dose group), ION-CCI + saline, and Sham. Mechanical allodynia and hyperalgesia were evaluated preoperatively (baseline) and on days 7, 14, and 21 postoperatively. After noxious mechanical stimulation of whisker pad skin, the number and distribution pattern of the phosphorylated extracellular signal-regulated kinase (pERK)-immunoreactive (IR) neurons were analyzed in the trigeminal spinal subnucleus caudalis (Vc) and upper cervical spinal cord (C1-C2). On day 21, nocifensive behavior was attenuated by high-dose but not low-dose BoNT-A administration. In addition, after noxious mechanical stimulation of whisker pad skin, the numbers of pERK-IR cells in the superficial laminae of Vc and C1-C2 were significantly lower in the high-dose BoNT-A group than in the ION-CCI + saline group. The present findings suggest that, by suppressing Vc neuronal activity, high-dose intradermal injection of BoNT-A at the site of ION innervation alleviates mechanical facial allodynia and hyperalgesia associated with ION-CCI.

KW - Allodynia

KW - BoNT-A

KW - Hyperalgesia

KW - ION-CCI

KW - pERK

UR - http://www.scopus.com/inward/record.url?scp=85007406133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007406133&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2016.11.043

DO - 10.1016/j.neulet.2016.11.043

M3 - Article

C2 - 27884737

AN - SCOPUS:85007406133

VL - 637

SP - 96

EP - 101

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

ER -